Transce3nd’s RXO RXO Stock Holding History

Transce3nd’s Portfolio RXO Stock Details RXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26	Closed	-$409	–	933
2025 Q2	$409	Hold	26	–	–	﹤0.01%	1113
2025 Q1	$497	Hold	26	–	–	﹤0.01%	1039
2024 Q4	$620	Buy	+26	New	+$726	﹤0.01%	1281

Other funds holding RXO

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Transce3nd's RXO Position: Q3 2025 in Review

Transce3nd sold out of RXO (RXO) in Q3 2025, closing a stake of 26 shares — an estimated $409 sold.

Transce3nd first reported a position in RXO in Q4 2024 and held it in 3 quarters. The position peaked at $620 in Q4 2024. 266 funds tracked by Wall St. Rank hold RXO as of Q3 2025.

Transce3nd reported no remaining RXO position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 26 RXO shares in Q3 2025, an estimated $409.
Transce3nd first reported a position in RXO in Q4 2024 and held it in 3 quarters.
Transce3nd's RXO position peaked at $620 in Q4 2024.
266 funds tracked by Wall St. Rank held RXO as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.